T 2126/18 of 03.08.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T212618.20230803
- Date of decision
- 3 August 2023
- Case number
- T 2126/18
- Online on
- 3 November 2023
- Petition for review of
- -
- Application number
- 10195509.4
- IPC class
- A61B 5/145
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Transcutaneous analyte sensor
- Applicant name
- DexCom, Inc.
- Opponent name
- Roche Diagnostics GmbH
- Board
- 3.2.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 76(1)European Patent Convention Art 83European Patent Convention Art 84European Patent Convention Art 123(2)
- Keywords
- Novelty - (yes)
Divisional application - subject-matter extends beyond content of earlier application (no)
Sufficiency of disclosure - (yes)
Claims - clarity (yes)
Amendments - added subject-matter (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form in the following version:
- claims 1-15 of the main request filed on 2 October
2017
- description: paragraphs 1-288, 290-293, 295-299 and
301-336 of the patent specification, and paragraphs
289, 294 and 300 filed on 3 July 2018
- the figures of the patent specification.